PUB - Publikationen an der Universität Bielefeld

Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compan, V., Tham, R., Kumke, T., Bauer, L., et al. (2022). An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 1097-1100). Hoboken: Wiley. https://doi.org/10.1002/art.42355

Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compan, V., Tham, R., Kumke, T., Bauer, L., Kim, M., and Gensler, L. (2022). “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis” in ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatology ed. Arthritis & Rheumatology, vol. 74, (Hoboken: Wiley), 1097-1100.

Rudwaleit, M., et al., 2022. An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. In American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. no.74 Hoboken: Wiley, pp. 1097-1100.

M. Rudwaleit, et al., “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis”, ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatology, ed., Arthritis & Rheumatology, vol. 74, Hoboken: Wiley, 2022, pp.1097-1100.

Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compan, V., Tham, R., Kumke, T., Bauer, L., Kim, M., Gensler, L.: An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. In: American College of Rheumatology (ed.) ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. 74, p. 1097-1100. Wiley, Hoboken (2022).

Rudwaleit, Martin, Van den Bosch, Filip, Marzo-Ortega, Helena, Navarro-Compan, Victoria, Tham, Rachel, Kumke, Thomas, Bauer, Lars, Kim, Mindy, and Gensler, Lianne. “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis”. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Ed. American College of Rheumatology. Hoboken: Wiley, 2022.Vol. 74. Arthritis & Rheumatology. 1097-1100.